Leonard S. Marks

The interpretation of serum prostate specific antigen in men receiving 5alpha-reductase inhibitors: a review and clinical recommendations.

Prevention of benign prostatic hyperplasia disease.

Editorial comment.

A multicenter study of [-2]pro-prostate specific antigen combined with prostate specific antigen and free prostate specific antigen for prostate cancer detection in the 2.0 to 10.0 ng/ml prostate specific antigen range.

Targeted biopsy in the detection of prostate cancer using an office based magnetic resonance ultrasound fusion device.

Prospective multicenter evaluation of the Beckman Coulter Prostate Health Index using WHO calibration.

Targeted prostate biopsy in select men for active surveillance: do the Epstein criteria still apply?

Improving risk stratification in patients with prostate cancer managed by active surveillance: nomogram predicting the risk of biopsy progression.

Screening and detection advances in magnetic resonance image-guided prostate biopsy.

Clinical validation of an epigenetic assay to predict negative histopathological results in repeat prostate biopsies.

Magnetic resonance imaging-ultrasound fusion biopsy for prediction of final prostate pathology.

Initial experience with electronic tracking of specific tumor sites in men undergoing active surveillance of prostate cancer.

A system for evaluating magnetic resonance imaging of prostate cancer using patient-specific 3D printed molds.

The prostate health index selectively identifies clinically significant prostate cancer.

Does the addition of targeted prostate biopsies to standard systemic biopsies influence treatment management for radiation oncologists?

MRI-Derived Restriction Spectrum Imaging Cellularity Index is Associated with High Grade Prostate Cancer on Radical Prostatectomy Specimens.

Multiparametric magnetic resonance imaging for prostate cancer improves Gleason score assessment in favorable risk prostate cancer.

Targeted Prostate Biopsy: Lessons Learned Midst the Evolution of a Disruptive Technology.

Serial Magnetic Resonance Imaging in Active Surveillance of Prostate Cancer: Incremental Value.

Focal Laser Ablation of Prostate Cancer: Phase I Clinical Trial.

The Relationship between Intolerance of Uncertainty and Anxiety in Men on Active Surveillance for Prostate Cancer.

Prostate cancer risk stratification with magnetic resonance imaging.

Magnetic Resonance Imaging Underestimation of Prostate Cancer Geometry: Use of Patient Specific Molds to Correlate Images with Whole Mount Pathology.

Targeted Biopsy to Detect Gleason Score Upgrading during Active Surveillance for Men with Low versus Intermediate Risk Prostate Cancer.

Focal Laser Ablation of Prostate Cancer.

Prostate Health Index improves multivariable risk prediction of aggressive prostate cancer.

Molecular Profiling to Determine Clonality of Serial Magnetic Resonance Imaging/Ultrasound Fusion Biopsies from Men on Active Surveillance for Low-Risk Prostate Cancer.

Re: A Pilot Study to Evaluate the Role of Magnetic Resonance Imaging for Prostate Cancer Screening in the General Population.

The First Filmed Prostatectomy, 1917: 100 Years of Movies in Urological Education.

Focal Laser Ablation of Prostate Cancer: Feasibility of Magnetic Resonance Imaging-Ultrasound Fusion for Guidance.

High Intensity Focused Ultrasound for Radiorecurrent Prostate Cancer: A North American Clinical Trial.

Value of Tracking Biopsy in Men Undergoing Active Surveillance of Prostate Cancer.

Focal Therapy Eligibility Determined by Magnetic Resonance Imaging/Ultrasound Fusion Biopsy.

Targeted Prostate Biopsy in the Era of Active Surveillance.

Development of a Nationally Representative Coordinated Registry Network for Prostate Ablation Technologies.

Editorial Comment.

A 17-Gene Genomic Prostate Score Assay Provides Independent Information on Adverse Pathology in the Setting of Combined Multiparametric Magnetic Resonance Imaging Fusion Targeted and Systematic Prostate Biopsy.

Exclusive MRI-targeted biopsy: not so fast.

Targeted and Systematic Biopsy for Diagnosis and Management of Prostate Cancer.

An Electronic Form for Reporting Results of Targeted Prostate Biopsy: Urology Integrated Diagnostic Report (Uro-IDR).

Editorial Comment.

Utilization of focal therapy for patients discontinuing active surveillance of prostate cancer: Recommendations of an international Delphi consensus.